Recurrence of cervical dysplasia (CIN) after treatment by LEEP

Stephen C. Rubin, MD
Ultima Vez Modificado: 14 de julio del 2002

Share article


Question

Dear OncoLink "Ask The Experts,"
My regular GYN just called me to tell me that my repeat Pap 1 year post LEEP was back to CIN 1. What is the incidence of recurrence (my initial abnormals were CIN 1-2) and what would you recommend next?  

Answer

Stephen C. Rubin, MD, Professor and Chief of the Division of Gynecologic Oncology, University of Pennsylvania Health System, responds:

The risk of recurrence of cervical dysplasia (CIN) after treatment by LEEP depends on a number of factors, including the degree and extent of the initial abnormality, the status of the surgical margins of the LEEP specimen, and others. In general, this risk of recurrence is approximately 10%, with most recurrences taking place within the first two years. An abnormal Pap smear at this point should be evaluated by colposcopy.


News
HPV Testing Post-CIN Treatment Found Cost Effective

Nov 7, 2012 - Women with a history of cervical intraepithelial neoplasia can be screened more cheaply and effectively post-treatment by testing for human papillomavirus, while women with CIN who complete post-treatment follow-up still have an increased risk of cervical cancer, according to two studies published online Nov. 1 in BMJ.



I Wish You Knew

How cancer patients have changed my life

View More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Frente a un nuevo diagnóstico de cáncer o de cambiar el curso de su tratamiento actual? Deje que nuestro personal de enfermería cáncer que ayudan a pasar!

Más información